23andMe is a consumer genomics company that provides direct-to-consumer DNA testing and ancestry services, along with personalized health insights and contributions to scientific research. Founded in 2006 by Anne Wojcicki, Linda Avey, and Paul Cusenza, the company went public via SPAC merger in 2021 and filed for Chapter 11 bankruptcy in March 2025, ultimately being acquired by TTAM Research Institute (a nonprofit led by founder Anne Wojcicki) for $305 million in 2025.
23andMe has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2006
Total Funding
$1.13B
10 rounds
Latest Valuation
$3.5B
November 3, 2023
Total raised $1.13B across 10 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
SPAC PIPE (Pre-IPO)
Date
February 4, 2021
Amount
$250M
Valuation
$3.5B
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| November 3, 2023 | Post-IPO | $20M | — | Anne Wojcicki |
| February 4, 2021 | SPAC PIPE (Pre-IPO) | $250M | $3.5B | Richard Branson, Anne Wojcicki |
| December 4, 2020 | Series F (later) | $82.5M | — | Sequoia Capital |
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Valuation indexed to 1.0× at the selected entry round. Valuation marks are estimates and may contain errors. Hover each dot to compare.
Entry · Series E
$1.1B
Oct 2015
23andMe today
$3.5B
Feb 2021 · latest mark
23andMe multiple
3.2x
valuation uplift since first round
Y-axis is logarithmic. Hollow dots = estimated valuations. Does not represent realized investor returns.
Anne Wojcicki
Co-Founder and former CEO
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Ancestry
Genealogy and DNA testing company providing ancestry insights and family tree construction
MyHeritage
Genealogy platform offering DNA testing and ancestry research services
Everlywell
At-home wellness testing company providing various health and diagnostic tests
Invitae
Genetic testing company focusing on clinical genomics and genetic counseling
Color Genomics
Genetic testing company specializing in cancer risk and preventative health screening
Illumina
Genomic sequencing and array technology provider enabling genetic research and testing
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.